RESUME CV

Paulette M. Furbert-Harris                                
Position Title    Assoc.  Prof of Microbiology/

                                                                              Director Core Laboratory

National Human Genome Center, Howard Univ.          

INSTITUTION AND LOCATION    DEGREE                YEAR(S)                FIELD OF STUDY        

Howard University, Washington, DC         BS/MS          1974 – 78          Zoology/Botany

Howard University, Washington, DC         Ph.D.            1986                 Microbiology

Laboratory of  Biology, DCE, NCI, NIH    Postdoctoral   1987-90            Tumor Imm

Laboratory of  Biology, DCE, NCI, NIH   Staff Fellow    1990-91            Tumor Imm

 RESEARCH AND PROFESSIONAL EXPERIENCE:

 Previous Employment

1991‑1992   Research Associate, Human Immunogenetics Laboratory, Howard University College of Medicine, Washington, DC

1992‑2000   Assistant Professor, Department of Microbiology, Howard University,   Washington, DC.

1994-2000   Co-Director of Immunogenetics Laboratory, Howard University, Washington, DC.

2000-Pres.   Associate Professor, Microbiology, Howard University College of Medicine,     Wash., DC

2003-Pres.   Director  of Core Laboratory, National Human Genome Center, Howard Univ.

 Professional Organizations

Member, American Association of Immunologists.

Associate Member, Sigma Xi

Member, AACR

  Honors

        1997- Kaiser-Permanente Award for Excellence in Teaching

        1998- AACR-HBCU Faculty Award in Cancer Research

        1998- AACR-HBCU Faculty Award: Special Prostate Cancer Conference

        1999- AACR-HBCU Faculty Award  in Cancer Research

         2000- AACR-HBCU Faculty Award  in Cancer Research

2004- Guest Editor Invitee for Cellular and Molecular Biology

Journal/Scientific Advisory Committees

I P Member, U.S. Army Medical Research and Materiel Command's (USAMRMC) Osteoporosis Program.

NIDDK Workshop on Studies in Minority Populations.  

Reviewer, Cellular and Molecular Sciences (2004)

Publications

Evans, C.H., Barnett, S.C., Gelleri, B.A., Furbert‑Harris, P.M., Sheehy,  P.A.,Barker, S.L., Baker, P.A., Wilson, A.C., Farley, B.K., and D'Allesandro, F.:Biological and molecular characteristics of leukoregulin action. In Gropman, J., Evans, C.H., and Golde (Eds.): Mechanisms of Action and Therapeutic Applications of Biologicals in Cancer and Immune Deficiency Disorders.  New York, Alan R. Liss, 1988,  Vol 100.

Furbert‑Harris, P.M., Evans, C.H., Woodworth, C.D., and DiPaolo, J.A.Loss of leukoregulin up‑regulation to NK not LAK lymphocytotoxicity  in human papilloma virus 16 DNA‑immortalized cervical epithelial cells. JNCI 81: 1080‑1085, 1989.

Furbert‑Harris, P.M., and Evans, C.H.  Leukoregulin up‑regulation of tumor cell sensitivity to natural killer and   lymphokine‑activated killer cell cytotoxicity. Cancer Immunol. Immunother. 30: 86‑91, 1989.

Evans, C.H., Furbert‑Harris, P.M., Woodworth, C.D., and DiPaolo, J.A.:  Lymphokine modulation of HPV 16 transfected cervical epithelial cell sensitivity to natural killer lymphocyte immunologic destruction.  In  Series, Vol 124.  New York, Wiley‑Liss, Inc., p. 145‑155, 1990.

DiPaolo, J.A., Woodworth, C.D., Furbert‑Harris, P.M., Evans, C.H.:  Immunomodulation of HPV 16 immortalized exocervical epithelial cells.  In Jablonska, S., Pfister, H., and Stegner, H.E. (Eds.):Genital Papillomavirus Infections: Advances in Modern   Diagnosis and Therapy.  Springer, Berlin‑Heidelberg‑New York pp 283‑299, 1990.

Evans, C.H., Furbert‑Harris, P.M., Flugelman, A.A., Woodworth, C.D., and DiPaolo, J.A.  Synergistic regulation of LAK lymphocyte cytotoxicity by combination cytokine and cisplatin treatment. Combination Therapies. eds A.L. Goldstein and E. Garaci, Plenum Press, New York p. 237-244, 1992.

A genome-wide search for asthma susceptibility loci in ethnically diverse populations; the collaborative study on the genetics of asthma (CSGA); center 1: Johns Hopkins - David G Marsh, et al; Howard University: Georgia M Dunston, Paulette Furbert-Harris, Floyd J Malveaux, Nature Genetics, 15:389-392, 1997.

Charmaine Royal, Ph.D., Agnes Baffoe-Bonnie, M.D., Ph.D., Rick Kittles, Ph.D., Isaac Powell, M.D., James Bennett, M.D., Gerald Hoke, M.D., Curtis Pettaway, M.D., Sally Weinrich, Ph.D., Srinivasan Vijayakumar, M.D., Chiledum Ahaghotu, M.D., Terry Mason, M.D., Edna Johnson, Michael Obeikwe, M.D., cheryl simpson, Raul Mejia, M.D., William Boykin, M.D., Pamela Roberson, Jacqueline Frost, Louise Faison-Smith, Carol Meegan, Norma Foster, Paulette Furbert-Harris, Ph.D., John Carpten, Ph.D., Joan Bailey-Wilson, Ph.D., Jeffrey Trent, Ph.D., Kate Berg, Ph.D., Georgia Dunston, Ph.D., Francis Collins, M.D., Ph.D. Recruitment Strategies in the First Phase of the African American Hereditary Prostate Cancer (AAHPC) Study. Annals Epidem. 2000. Nov; 10(8 Suppl): S68-77.

Berka N, Bland GN, Gause DP, Furbert-Harris P, Erabhaoui EH, Bonar S, Okeapu D, and Dunston GM. 2000.  Early age of disease onset in african american type 1 diabetes patients is associated with DQB1*0101 allele.  Human Immunology. 61, 816-819 (2000).

Charles N Rotimi, Georgia M Dunston, Kate Berg, Omobosola Akinsete, Albet Amoah, Samuel Owusu, Joseph Acheampong, Kofi Boateng, Johnnie Oli, Godfrey Okafor, Babatunde Osotimehin, Fayeofori Abbiyesuku, Thomas Johnson, Paulette Furbert-Harris, Rick Kittles, Mirjana Vekich, Olufeme Adegoke, George Bonney, Frances Collins.  In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study.  Annals Epid 2001. Jan; 11(1): 51-58.

Publications Continued:

Furbert-Harris PM, Laniyan I, Harris D, Dunston GM, Vaughn T, Abdelnaby A, Parish-Gause D, Oredipe OA. Activated eosinophils infiltrate MCF-7 breast multicellular tumor spheroids. Anticancer Res. 2003 Jan-Feb; 23(1A):71-8.

PM Furbert-Harris, D Parish-Gause, I Laniyan, J Okomo-Awich, T Vaughn, KC Forrest, C Howland, A Abdelnaby, OA Oredipe. Inhibition of prostate cancer cell growth by activated eosinophils. The Prostate 2003; 57:165-175.

Oredipe OA, Furbert-Harris PM, Green WR, White SL, Olden K, Laniyan I, Parish-Gause D, Vaughn T, Griffin WM, Sridhar R. Swainsonine stimulates bone marrow cell proliferation in different strains of inbred mice. Pharmacol Res. 2003. Jan; 47(1):69-74.

Oredipe OA, Furbert-Harris PM, Laniyan I, Green WR, White SL, Olden K, Parish-Gause D, Vaughn T, Griffin WM Sridhar R.Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine. Int  Immunopharmacol 2003. Mar; 3(3):445-55.

Oladipo A. Oredipe, Paulette Furbert-Harris, I Laniyan, WM Griffin, R Sridhar. Limits of stimulation of proliferation and differentiation of bone marrow cells of mice treated with swainsonine.  Int  Immunopharmacology 2003; 3: 1537-1547.

Paulette M. Furbert-Harris, Debra Parish-Gause, Keith A Hunter, Theresa R Vaughn, Christina Howland, Josephine Okomo-Awich, Kesha C. Forrest, Ibrahim Laniyan, Abier Abdelnaby, and Oladipo A. Oredipe. Activated esinophils uregulate the metastasis suppressor molecule e-cadherin on prostate tumor cells. Cellular and Molecular  Biology 2003. Nov; 49(7):1009-1016.

Paulette M. Furbert-Harris, Keith A. Hunter, Theresa R. Vaughn, Debra Parish-Gause, Ibrahim Laniyan, Dana Harris, Josephine Okomo-Awich, K Forrest, and Oladipo A. Oredipe. Eosinophils in a Tri-Cell Multicellular Tumor Spheroid (MTS)/Endothelium Complex. Cellular and Molecular Biology 2003. Nov, 49(7):1081-1088.

Oladipo A. Oredipe, Paulette Furbert-Harris, I Laniyan, WR Green, WM Griffin, R Sridhar. Mice primed with swainsonine are protected against doxorubicin-induced lethality. Cellular and Molecular Biology 2003. Nov, 49(7):1089-1099.

Oladipo A. Oredipe, Paulette Furbert-Harris, I Laniyan, WR Green, WM Griffin, R Sridhar. Coadministration of swainsonine and doxorubicin attenuates doxorubicin-induced lethality in mice. Cellular and Molecular Biology 2003. Nov, 49(7):1037-1048.

Rotimi CN, Chen G, Adeyemo AA, Furbert-Harris P, Parish-Gause D, Zhou J, Berg K, Adegoke O, Amoah A, Owusu S, Acheampong J, Agyenim-Boateng K, Eghan BA Jr, Oli J, Okafor G, Ofoegbu E, Osotimehin B, Abbiyesuku F, Johnson T, Rufus T, Fasanmade O, Kittles R, Daniel H, Chen Y, Dunston G, Collins FS. A genome-wide search for type 2 diabetes susceptibility genes in West Africans: the Africa America Diabetes Mellitus (AADM) Study. Diabetes. 2004 Mar; 53(3):838-41.
Selected Published Abstracts

Furbert-Harris, PM, GL Ellison, I Laniyan, DP Gause, T Vaughn, GM Dunston, and CN  Rotimi. Association between Tumor Necrosis Factor-alpha (TNF-") and Correlates of Insulin Resistance in a Cohort of Type 2 Diabetic Patients from West Africa. 17^th  Diabetes Federation Congress , 2000.

Furbert-Harris PM, Harris D, Laniyan I, Hunter KA, Vaughn T, Adelnaby A, Parish-Gause D, Awich J, Howland C, and Oredipe O.  Use of multicellular tumor spheroids as a model of eosinophil:tumor interaction.  Proceedings of AACR, 2003.